The mRNA Writing On The Wall, GSK Expands CureVac Alliance Into Next-Gen COVID-19 Vaccines

Includes 100m Dose Boost To CureVac's COVID-19 Manufacturing

After major setbacks to its existing COVID-19 vaccine platform, GSK is expanding its presence in mRNA, which increasingly looks to be the future.  

GSK HQ
GSK is one of the world's biggest vaccines companies, but is not a leader in the fast-emerging mRNA field.

GlaxoSmithKline has given further weight to the belief that mRNA technology is the future of vaccines by expanding its alliance with CureVac into next generation COVID-19 vaccines.

The UK-headquartered company is one of the world’s biggest vaccines manufacturers, but has seen its partnership with Sanofi on developing...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip